Cargando…
Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia
INTRODUCTION: Previous studies have highlighted the importance of polymorphisms of toll-like receptors (TLRs) in the pathogenesis of certain cancers, including head and neck cancers (HNC). AIM OF THE STUDY: The aim of this study was to evaluate the association of TLR2 (-196 to -174 ins/del) and TLR3...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Society of Experimental and Clinical Immunology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745549/ https://www.ncbi.nlm.nih.gov/pubmed/31530984 http://dx.doi.org/10.5114/ceji.2019.87065 |
_version_ | 1783451565166690304 |
---|---|
author | Makni, Lamia Zidi, Sabrina Barbiroud, Mouadh Ahmed, Amira Ben Gazouani, Ezzedine Mezlini, Amel Stayoussef, Mouna Yacoubi-Loueslati, Besma |
author_facet | Makni, Lamia Zidi, Sabrina Barbiroud, Mouadh Ahmed, Amira Ben Gazouani, Ezzedine Mezlini, Amel Stayoussef, Mouna Yacoubi-Loueslati, Besma |
author_sort | Makni, Lamia |
collection | PubMed |
description | INTRODUCTION: Previous studies have highlighted the importance of polymorphisms of toll-like receptors (TLRs) in the pathogenesis of certain cancers, including head and neck cancers (HNC). AIM OF THE STUDY: The aim of this study was to evaluate the association of TLR2 (-196 to -174 ins/del) and TLR3 (1377 C>T) as potential risk factors for HNC in Tunisians. MATERIAL AND METHODS: A case-control study including 246 HNC patients (174 nasopharyngeal carcinoma – NPC and 72 laryngeal cancer – LC) and 250 healthy controls. Genotyping was done by using PCR and PCR-RFLP methods. RESULTS: Higher minor allele frequencies of TLR2 (-196 to -174 ins/del) and TLR3 1377 C>T polymorphisms were seen in HNC, NPC, and LC compared to controls. In addition, higher increased HNC, NPC, and LC risk was associated with TLR2 ins/del and TLR2 del/del genotypes (p < 0.0001). Positive association with HNC, NPC, and LC risk was seen with TLR2 del-containing genotypes (ins/del + del/del) (p < 0.0001). The T/T genotype of TLR3 is associated with HNC, NPC, and LC susceptibility (p < 0.0001). Positive association with HNC and NPC risk was seen with TLR3 T allele carriers (C/T + T/T) (p < 0.0001). Increased frequency of T-ins, C-del, and T-del haplotypes was revealed in HNC and NPC cases than healthy controls; however, T-del was significantly higher in LC cases. CONCLUSIONS: Our results demonstrate an increased risk of HNC, NPC, and LC with TLR2 ins/del, TLR2 del/del, and TLR3 T/T genotypes. And positive association with T-ins, C-del, and T-del haplotypes with HNC and NPC and T-del haplotype with LC. |
format | Online Article Text |
id | pubmed-6745549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Polish Society of Experimental and Clinical Immunology |
record_format | MEDLINE/PubMed |
spelling | pubmed-67455492019-09-17 Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia Makni, Lamia Zidi, Sabrina Barbiroud, Mouadh Ahmed, Amira Ben Gazouani, Ezzedine Mezlini, Amel Stayoussef, Mouna Yacoubi-Loueslati, Besma Cent Eur J Immunol Clinical Immunology INTRODUCTION: Previous studies have highlighted the importance of polymorphisms of toll-like receptors (TLRs) in the pathogenesis of certain cancers, including head and neck cancers (HNC). AIM OF THE STUDY: The aim of this study was to evaluate the association of TLR2 (-196 to -174 ins/del) and TLR3 (1377 C>T) as potential risk factors for HNC in Tunisians. MATERIAL AND METHODS: A case-control study including 246 HNC patients (174 nasopharyngeal carcinoma – NPC and 72 laryngeal cancer – LC) and 250 healthy controls. Genotyping was done by using PCR and PCR-RFLP methods. RESULTS: Higher minor allele frequencies of TLR2 (-196 to -174 ins/del) and TLR3 1377 C>T polymorphisms were seen in HNC, NPC, and LC compared to controls. In addition, higher increased HNC, NPC, and LC risk was associated with TLR2 ins/del and TLR2 del/del genotypes (p < 0.0001). Positive association with HNC, NPC, and LC risk was seen with TLR2 del-containing genotypes (ins/del + del/del) (p < 0.0001). The T/T genotype of TLR3 is associated with HNC, NPC, and LC susceptibility (p < 0.0001). Positive association with HNC and NPC risk was seen with TLR3 T allele carriers (C/T + T/T) (p < 0.0001). Increased frequency of T-ins, C-del, and T-del haplotypes was revealed in HNC and NPC cases than healthy controls; however, T-del was significantly higher in LC cases. CONCLUSIONS: Our results demonstrate an increased risk of HNC, NPC, and LC with TLR2 ins/del, TLR2 del/del, and TLR3 T/T genotypes. And positive association with T-ins, C-del, and T-del haplotypes with HNC and NPC and T-del haplotype with LC. Polish Society of Experimental and Clinical Immunology 2019-07-30 2019 /pmc/articles/PMC6745549/ /pubmed/31530984 http://dx.doi.org/10.5114/ceji.2019.87065 Text en Copyright: © 2019 Polish Society of Experimental and Clinical Immunology http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Clinical Immunology Makni, Lamia Zidi, Sabrina Barbiroud, Mouadh Ahmed, Amira Ben Gazouani, Ezzedine Mezlini, Amel Stayoussef, Mouna Yacoubi-Loueslati, Besma Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia |
title | Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia |
title_full | Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia |
title_fullStr | Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia |
title_full_unstemmed | Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia |
title_short | Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia |
title_sort | increased risks between tlr2 (-196 to -174 ins/del) and tlr3 1377c>t variants and head and neck cancers in tunisia |
topic | Clinical Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745549/ https://www.ncbi.nlm.nih.gov/pubmed/31530984 http://dx.doi.org/10.5114/ceji.2019.87065 |
work_keys_str_mv | AT maknilamia increasedrisksbetweentlr2196to174insdelandtlr31377ctvariantsandheadandneckcancersintunisia AT zidisabrina increasedrisksbetweentlr2196to174insdelandtlr31377ctvariantsandheadandneckcancersintunisia AT barbiroudmouadh increasedrisksbetweentlr2196to174insdelandtlr31377ctvariantsandheadandneckcancersintunisia AT ahmedamiraben increasedrisksbetweentlr2196to174insdelandtlr31377ctvariantsandheadandneckcancersintunisia AT gazouaniezzedine increasedrisksbetweentlr2196to174insdelandtlr31377ctvariantsandheadandneckcancersintunisia AT mezliniamel increasedrisksbetweentlr2196to174insdelandtlr31377ctvariantsandheadandneckcancersintunisia AT stayoussefmouna increasedrisksbetweentlr2196to174insdelandtlr31377ctvariantsandheadandneckcancersintunisia AT yacoubiloueslatibesma increasedrisksbetweentlr2196to174insdelandtlr31377ctvariantsandheadandneckcancersintunisia |